ITM, a pioneer in radiopharmaceuticals, said it will submit its first drug for approval after reporting the therapy halted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback